Oncology nurses play a critical role in identifying and managing rare audiovestibular complications associated with immune ...
This analysis of patients with previously treated advanced clear cell renal cell carcinoma treated with belzutifan is the ...
Three-year findings from the TRANSFORM trial provide further evidence that liso-cel should be considered as the new standard ...
The updated risk evaluation and mitigation strategies for autologous CAR T-cell therapy removed requirements for training and ...
An oncology nurse's experience with her mother's cancer and her own BRCA2 diagnosis shapes her approach to patient care.
A durvalumab-based combination followed by an olaparib-based maintenance therapy improved progression-free survival in newly ...
The winner of the 2024 Extraordinary Healer® award, Meaghan Mooney, BSN, RN, OCN, found a rewarding career caring for ...
Final results of the ARMANI trial demonstrated that switch maintenance therapy with ramucirumab plus paclitaxel improved survival in advanced HER2-negative gastric or gastroesophageal junction cancer.
With several options available for the second-line treatment of HR-positive, HER2-negative mBC, an expert emphasized the ...
Maternal or pregnancy outcomes were not negatively affected by the use of assisted reproductive techniques (ART) in patients ...
Daniel Verina, DNP, ACNP-BC, discussed how CAR T-cell therapy is changing the treatment landscape for patients with multiple myeloma. CAR T-cell therapy represents a significant advancement in the ...
What should a patient do when there is an incidental finding on radiographic films? Is the patient responsible for following up, or is it the responsibility of the provider who ordered the imaging?